In fact, one study even shows that galantamine, an acetylcholinesterase inhibitor used in the treatment of Alzheimer׳s disease, promotes adult DG neurogenesis via α7⁎nAChRs (Kita et al., 2014), making this a very promising avenue for future research. This evidence concerns the gene CHRNA7 and early-onset autosomal dominant Alzheimer disease.